Literature DB >> 34916781

Telemedicine During the COVID-19 Pandemic: A Paradigm Shift in Non-Communicable Disease Management? - A Cross-Sectional Survey from a Quaternary-Care Center in South India.

Sisira Ullas1, Manu Pradeep2, Sandeep Surendran3, Anjali Ravikumar4, Anna Maria Bastine1, Ayush Prasad1, Aravind Mohan1.   

Abstract

PURPOSE: This study aims to gauge the perception and adoption rates of telemedicine amongst patients with non-communicable diseases (NCD) as opposed to in-person consultations in a quaternary care center in South India. PATIENTS AND METHODS: A web-hosted 21-item cross-sectional survey was distributed to 220 randomly selected patients with a routine appointment in one of the seven departments caring for NCDs in the study center. Descriptive analysis and inferential analyses were done. Paired samples T-test and Pearson's Chi-square test were used study associations.
RESULTS: In-person consultations decreased by 1.9±4.47 visits per year, in 2020 vs 2019. Most participants reported "fear of COVID-19" as the primary reason for this decline. Participants also reported that their consultation times had significantly decreased (OR=6.43, 95% CI=1.7-24.08, p=0.006). The decreased consultations time, difficulty in obtaining in-person appointments, along with the reduced physical examination during consultations have made participants more open to the idea of teleconsultations (OR=3.88, 95% CI=1.21-12.47, p=0.022). Eighty-five (38.63%) participants had already adopted telemedicine for their routine consultations during the pandemic. Whilst participants felt that telemedicine was an adequate surrogate for in-person consultations, a significant difficulty in obtaining medications was noted (OR=6, 95% CI=1.34-26.81, p=0.019).
CONCLUSION: In-person consultations were decreased primarily due to the perception of significant risk of COVID-19 exposure in the present scenario. Telemedicine adoption in the private sector may be sustainable throughout the pandemic and beyond, if patients are offered to continue their routine consultations with their regular doctors and ensured medicine availability. Integration of telemedicine by the public and private health sector of India into routine NCD care delivery is the need of the hour, but further studies are required to estimate the effectiveness of the systems.
© 2021 Ullas et al.

Entities:  

Keywords:  COVID-19; India; chronic disease; patient compliance; telemedicine

Year:  2021        PMID: 34916781      PMCID: PMC8667749          DOI: 10.2147/PPA.S332636

Source DB:  PubMed          Journal:  Patient Prefer Adherence        ISSN: 1177-889X            Impact factor:   2.711


  18 in total

1.  Telemedicine and the COVID-19 Pandemic, Lessons for the Future.

Authors:  Rashid Bashshur; Charles R Doarn; Julio M Frenk; Joseph C Kvedar; James O Woolliscroft
Journal:  Telemed J E Health       Date:  2020-04-08       Impact factor: 3.536

2.  Using Telemedicine During the COVID-19 Pandemic.

Authors:  Vidushi Mahajan; Tanvi Singh; Chandrika Azad
Journal:  Indian Pediatr       Date:  2020-05-14       Impact factor: 1.411

3.  Implications of telehealth and digital care solutions during COVID-19 pandemic: a qualitative literature review.

Authors:  Bokolo Anthony Jnr
Journal:  Inform Health Soc Care       Date:  2020-11-29       Impact factor: 2.439

4.  Non-communicable disease management in vulnerable patients during Covid-19.

Authors:  Saurav Basu
Journal:  Indian J Med Ethics       Date:  2020 Apr-Jun

5.  What was right about Kerala's response to the COVID-19 pandemic?

Authors:  Jaideep C Menon; P S Rakesh; Denny John; Rajesh Thachathodiyl; Amitava Banerjee
Journal:  BMJ Glob Health       Date:  2020-07

Review 6.  Telemedicine in India: Where do we stand?

Authors:  Vinoth G Chellaiyan; A Y Nirupama; Neha Taneja
Journal:  J Family Med Prim Care       Date:  2019-06

7.  Telemedicine During the COVID-19 Pandemic: Experiences From Western China.

Authors:  Zhen Hong; Nian Li; Dajiang Li; Junhua Li; Bing Li; Weixi Xiong; Lu Lu; Weimin Li; Dong Zhou
Journal:  J Med Internet Res       Date:  2020-05-08       Impact factor: 5.428

8.  Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.

Authors:  Anjali Verma; Rajesh Rajput; Surender Verma; Vikas K B Balania; Babita Jangra
Journal:  Diabetes Metab Syndr       Date:  2020-07-13

9.  Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: A hospital-based cross-sectional survey from South India.

Authors:  Prasanth Sankar; Waseem N Ahmed; Vineetha Mariam Koshy; Rittin Jacob; Saranya Sasidharan
Journal:  Diabetes Metab Syndr       Date:  2020-09-11

10.  The impact of COVID-19 on people with diabetes in Brazil.

Authors:  Mark Thomaz Ugliara Barone; Simone Bega Harnik; Patrícia Vieira de Luca; Bruna Letícia de Souza Lima; Ronaldo José Pineda Wieselberg; Belinda Ngongo; Hermelinda Cordeiro Pedrosa; Augusto Pimazoni-Netto; Denise Reis Franco; Maria de Fatima Marinho de Souza; Deborah Carvalho Malta; Viviana Giampaoli
Journal:  Diabetes Res Clin Pract       Date:  2020-07-03       Impact factor: 8.180

View more
  1 in total

1.  Perceptions about Telemedicine among Populations with Chronic Diseases amid COVID-19: Data from a Cross-Sectional Survey.

Authors:  Miah Md Akiful Haque; Yasmin Jahan; Zara Khair; Michiko Moriyama; Md Moshiur Rahman; Mohammad Habibur Rahman Sarker; Shamsun Nahar Shaima; Sajeda Chowdhury; Kazi Farhana Matin; Ishrat Jahan Karim; Mostafa Taufiq Ahmed; Syed Zakir Hossain; Md Adnan Hasan Masud; Mohammad Golam Nabi; Asma Binte Aziz; Mohiuddin Sharif; Md Forhadul Islam Chowdhury; Kaniz Laila Shams; Nusrat Benta Nizam; Taiyaba Tabassum Ananta; Md Robed Amin; Mohammad Delwer Hossain Hawlader
Journal:  Int J Environ Res Public Health       Date:  2022-04-02       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.